CDT Equity Inc. logo

CDT Equity Inc.

CDT | NASDAQ
Chart Builder DCF Calculator
$0.47
$0.00 (0.00%)
Nov 2, 2026, 12:00 PM ET · Market open
+0.00%

No price chart data available for 1D timeframe.

Rating

Updated: Oct 6, 2026
40.5
Fundamentals Average
Market Sentiment Neutral
Moat None

Key Statistics

Market Data

Market Cap $366.1K
1D Range
0.42 0.59
52W Range
0.42 28,125

Valuation (TTM)

PE 0
PB 0.00
EV/EBITDA 4.60

Valuation (NTM)

Forward PE N/A
Forward PEG -0.00
Price Target N/A
Loading financial charts...

Profile

CDT Equity Inc., a data-driven biopharmaceutical company, focuses on identifying, enhancing, and monetising therapeutic assets. The company’s pipeline includes AZD1656, a glucokinase activator that is...

Sector Healthcare
Industry Biotechnology
Employees 4
IPO Date Mar 28, 2022
Fiscal Year January - December

Latest News

CDT Highlights Sarborg's Expanding Quantum Computing IP Portfolio and Application to Drug Discovery

1 month ago · globenewswire.com

CDT Highlights Sarborg's Expanding Quantum Computing IP Portfolio and Application to Drug Discovery
CDT Equity Inc. Announces Reverse Stock Split

1 month ago · globenewswire.com

CDT Equity Inc. Announces Reverse Stock Split
CDT Partners with QIMA Life Sciences to Evaluate Novel Tapinarof Combinations in Psoriasis and Vitiligo

2 months ago · globenewswire.com

CDT Partners with QIMA Life Sciences to Evaluate Novel Tapinarof Combinations in Psoriasis and Vitiligo
CDT Highlights Sarborg's Application of Signature Intelligence and Quantum Computing Models to Mental Health

2 months ago · globenewswire.com

CDT Highlights Sarborg's Application of Signature Intelligence and Quantum Computing Models to Mental Health
CDT Provides Capital Update and Confirms No Nasdaq Deficiencies

2 months ago · globenewswire.com

CDT Provides Capital Update and Confirms No Nasdaq Deficiencies
CDT Appoints Co-Founder James Bligh as Chief Executive Officer to Lead Next Phase of Growth

2 months ago · globenewswire.com

CDT Appoints Co-Founder James Bligh as Chief Executive Officer to Lead Next Phase of Growth
CDT Validates Enhanced Solid-Form Properties Within Its IP Portfolio

2 months ago · globenewswire.com

CDT Validates Enhanced Solid-Form Properties Within Its IP Portfolio
CDT Announces Investment in Pep'd, Expanding into the Fast-Growing US Peptide Market

2 months ago · globenewswire.com

CDT Announces Investment in Pep'd, Expanding into the Fast-Growing US Peptide Market
CDT Increases Stake in Sarborg following its Quantum Computing and Intellectual Property Expansion

3 months ago · globenewswire.com

CDT Increases Stake in Sarborg following its Quantum Computing and Intellectual Property Expansion
CDT Environmental Technology Announces Results of Extraordinary General Meeting

3 months ago · globenewswire.com

CDT Environmental Technology Announces Results of Extraordinary General Meeting

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.